baber/WOPTO huggingface dataset:
Patent NZ-304291-A (NZ)
Title: Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof
Inventor: NUSSBAUMER PETER
IPC: C07D239/94
Filed: 1996-03-14
Abstract: PCT No. PCT/EP96/01116 Sec. 371 Date Sep. 15, 1997 Sec. 102(e) Date Sep. 15, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/28430 PCT Pub. Date Sep. 19, 1996The invention concerns compounds of formula I wherein the substituents have various meanings, and their use in the prevention or treatment of inflammatory and proliferative skin diseases and cancer.
Patent NZ-307369-A (NZ)
Title: Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
Inventor: KLUNK WILLIAM E
IPC: G01N33/68
Filed: 1996-05-01
Abstract: Amyloid binding compounds which are derivatives of Chrysamine G, pharmaceutical compositions containing, and methods using such compounds to identify Alzheimer's brain in vivo and to diagnose other pathological conditions characterized by amyloidosis, such as Down's Syndrome are described.  Pharmaceutical compositions containing Chrysamine G and derivatives thereof and methods using such compositions to prevent cell degeneration and amyloid-induced toxicity in amyloidosis associated conditions are also described. Methods using Chrysamine G derivatives to stain or detect amyloid deposits in biopsy or post-mortem tissue are also described.  Methods using Chrysamine G derivatives to quantify amyloid deposits in homogenates of biopsy and post-mortem tissue are also described.
Patent NZ-311175-A (NZ)
Title: Gene preparation comprising a gene incorporated into a biocompatible carrier which preferably contains collagen
Inventor: TERADA MASAAKI
IPC: A61K48/00
Filed: 1996-07-02
Abstract: Gene preparations comprising desired genes or vectors containing desired genes integrated into them and carriers for supporting the same.
Patent NZ-328783-A (NZ)
Title: Sustained release composition containing nifedipine and polyvinyl pyrrolidine
Inventor: VALDUCCI ROBERTO
IPC: A61K47/32
Filed: 1997-09-18
Abstract: Controlled release pharmaceutical compositions for the oral administration of nifedipine comprising an amorphous coprecipitate of nifedipine and polyvinylpyrrolidone and suitable excipients, the release being modulable from 8 to 24 hours modifying the amount and the kind of used excipients. Said compositions show a high solubility and bioavailability in addition to the advantage of the controlled release.
Patent NZ-334834-A (NZ)
Title: Branched primary alcohol compositions having 1 to 36 carbon atoms and 0.7 to 3.0 branches per molecule, and biodegradable detergents made therefrom
Inventor: KRAVETZ LOUIS
IPC: C07C29/16
Filed: 1997-11-25
Abstract: There is provided a branched primary alcohol composition and the sulfates, alkoxylates, alkoxy sulfates and carboxylates thereof which exhibit good cold water detergency and biodegradability. The branched primary alcohol composition has an average number of branches per chain of 0.7 to 3.0, having at least 8 carbon atoms and containing both methyl and ethyl branches. The primary alcohol composition may also contain less than 0.5 atom% of quaternary carbon atoms, and a significant number of ethyl branches, terminal isopropyl branches, and branching at the C3 position relative to the hydroxyl carbon. The process for its manufacture is by skeletally isomerizing an olefin feed having at least 7 carbon atoms or by dimerising a C6-C10 olefin, followed by conversion to an alcohol, as by way of hydroformylation, and ultimately sulfation, alkoxylation or both to obtain a detergent surfactant. Useful skeletal isomerization catalysts include the zeolites having at least one channel with a crystallographic free diameter along the x and/or y planes of the [001] view ranging from 42 to 70 nanometer. Useful dimerisation catalysts include a combination of a nickel carboxylate with an alkyl aluminium halids, or a combination of a nickel chelate with an alkyl aluminium alkoxide.
Patent NZ-336873-A (NZ)
Title: Topical use of premafloxacin and premafloxacin esters to treat or prevent systemic bacterial disease
Inventor: WATTS JEFFREY L
IPC: A61K31/47
Filed: 1997-05-05
Abstract: The present invention provides a method of topically administering antimicrobial agents such as premafloxacin, premafloxacin-like compound, premafloxacin ester, ciprofloxacin, enrofloxacin, cefquinome, cefpodoxime, gentamicin or erythromycin for the treatment of systemic bacterial diseases in mammals.
Patent NZ-338002-A (NZ)
Title: Molding multi-layered articles using coinjection techniques
Inventor: BECK MARTIN H
IPC: B29C45/16
Filed: 1998-04-01
Abstract: A multi-cavity coinjection mould and method for simultaneously producing a plurality of multi-layered articles comprising: a mould structure defining a plurality of mould cavities; a first supply source for supplying metered amounts of a first moulding material; a second supply source for supplying metered amounts of a second moulding material; a hot runner system in communication with the first and second supply sources for conveying the metered amounts of the first and the second materials separately to a region proximate each of the cavities; a valve mechanism per cavity for receiving the metered amounts of the first and second materials from the hot runner system and for sequentially supplying desired quantity of the first and second materials contiguously to each cavity.
Patent NZ-505245-A (NZ)
Title: Pharmaceutical compositions of itraconazole and a water-soluble polymer to treat fungal infection
Inventor: GILIS PAUL MARIE VICTOR
IPC: C07D405/14
Filed: 1999-07-09
Abstract: Described are pellets of itraconazole in an oral dosage form comprising a 710-1180 micron (16-25 mesh) sugar core, a coating film of a water-soluble polymer and an antifungal agent, and a seal coating layer wherein the residual concentration of dichloromethane is below 600 ppm.  Pharmaceutical dosage forms comprising these pellets and a method of preparing them are also described.
Patent NZ-506911-A (NZ)
Title: Modulate of bovine myostatin for increasing muscle mass or weight in animals
Inventor: BARKER CHRISTOPHER A
IPC: C07K16/22
Filed: 1999-02-19
Abstract: A  myostatin multimer comprises two or  more  selected myostatin  immunogens.   Each of  the  myostatin  immunogens independently comprises an amino acid sequence selected from the  group consisting of amino acids 3-18, inclusive of  SEQ ID  NO:4; amino acids 3-15, inclusive of SEQ ID NO:6;  amino acids  3-17,  inclusive, of SEQ ID NO:8; amino  acids  3-16, inclusive  of  SEQ ID NO:10; amino acids 3-22, inclusive  of SEQ  ID  NO:12; amino acids 3-25, inclusive of SEQ ID NO:14; amino acids 3-22, inclusive of SEQ ID NO:16; amino acids  3- 19,  inclusive, of SEQ ID NO:18; amino acids 3-18, inclusive of  SEQ ID NO:20; and amino acids 3-18, inclusive, of SEQ ID NO:22.   Also  described are myostatin multimers  comprising two or more selected myostatin immunogens.  At least one  of the  selected myostatin immunogens comprises the amino  acid sequence  Lys-Arg-Ser-Arg-Arg-Asp (SEQ ID NO:37) or Lys-Glu- Asn-Val-Glu-Lys-Glu  (SEQ ID NO:38) or  Ser-Leu-Lys-Asp-Asp- Asp (SEQ ID NO:39). The  myostatin multimers can be use din vaccine compositions to  elicit an immune response against a myostatin immunogen. The  immune  response  may result in at  least  one  of  the biological effects selected from an increase in body weight, an  increase  in muscle mass, an increase in the  number  of muscle  cells,  an increase in the size of muscle  cells,  a reduction  in  body  fat  content,  am  increase  in  muscle strength,  an increase in mammary gland tissue, an  increase in  lactation, an increase in appetite or feed uptake or  an increase  in  the  life span of the subject.  The  myostatin multimer  can  also be used to manufacture a medicament  for treating a disorder which comprises degeneration or  wasting of muscle.
Patent NZ-508532-A (NZ)
Title: Method for promoting smoking cessation or reduction or preventing relapse smoking
Inventor: STEINER MARTIN X
IPC: A61P25/34
Filed: 1999-06-16
Abstract: A method for promoting smoking cessation or reduction or preventing relapse smoking, comprises administering an effective, non-toxic amount of paroxetine or a pharmaceutically acceptable salt or solvate thereof, to human in need thereof.
Patent NZ-512739-A (NZ)
Title: 2-amino-benzoxazinone derivatives for the treatment of obesity
Inventor: CARR BEVERLEY JAN
IPC: A61P3/00
Filed: 2000-01-06
Abstract: Use of compounds of formula (I) for treating conditions requiring the inhibition of an enzyme that catalyses the hydrolysis of ester functionalities, namely obesity related disorders. Also disclosed are derivative compounds of formula (IIa) and methods for their preparation.
Patent NZ-515445-A (NZ)
Title: Process set and methods for processing and treating a biological fluid
Inventor: CLARKE MICHAEL S
IPC: A61M1/02
Filed: 2000-05-31
Abstract: Apparatus (10), systems and methods are disclosed  for treating  a  biological fluid with light. A container  (206) of  biological  fluid is introduced into a  fluid  treatment chamber  (40) where it is contacted with light  provided  by one  or  more  light sources (60, 70) in  proximity  to  the fluid  treatment  chamber (40). A drawer  (50)  for  holding containers  of  biological fluid introduces  the  containers (206)  into  the chamber (40). Containers (206) for  holding the  biological  fluid are marked by the apparatus  (10)  to indicate the status of the treatment.
Patent NZ-519862-A (NZ)
Title: Marketing response recording using short message service text word comparisons
Inventor: SMITH GLEN DAVID
IPC: G06Q30/02
Filed: 2000-04-07
Abstract: At  least one predetermined text string which  may  be either a single word or more within a message received by  a destination  number  for  an  interactive  marketing  and/or survey  system  utilizing  a short message  system  protocol (SMS)  is  detected  and  the  message  that  includes   the detected text string is routed to a specific message  system client  application  on the basis of the  existence  of  the predetermined  text string. A reply message is  returned  to the   originator  indicating  that  the  message  has   been received by the particular client application intended.  The count  of  the number of messages allocated to  each  client application is available from a message recorder.
Patent NZ-522105-A (NZ)
Title: Method for monitoring condition of bearings of a crusher, and a crusher with friction force sensing
Inventor: NIEMINEN IIPO
IPC: G01L5/00
Filed: 2002-03-13
Abstract: Malfunctions of sliding bearings of gyratory crushers used in crushing stone are anticipated by providing sensors in connection to bearings parts, by means of which sensors it is possible to observe increases in friction forces. A beginning bearing damage can be detected by means of sensors at such an early stage, that extensive damage to bearings and to other parts of the crusher can be prevented.
Patent NZ-526185-A (NZ)
Title: Method and apparatus for constructing an end portion of a food sauce dispensing cartridge
Inventor: ROBERTSON RONALD D
IPC: B31B50/64
Filed: 2001-08-30
Abstract: A method and apparatus for constructing a dispensing end portion of a cartridge used to hold and dispense food sauce. A flat end disk (18) is held in a transfer pocket and moved by a disk punch through a die opening smaller in diameter than the disk. The die bends the peripheral portion of the disk into a skirt. The disk punch inserts the disk into the open end (16) of a cartridge body (10) and against a mandrel positioned so that an end portion of the cartridge body extends beyond the skirt. Heat is applied to melt thermoplastic coatings (14, 20) on the disk and cartridge body. A crimping device crimps the end portion oft he cartridge into a flange which is bent against the disk and folds the skirt to form a lip doubled over on the peripheral area of the disk. Thermoplastic coatings bond to weld the flange to the disk with the lip enclosed between them.
Patent NZ-526593-A (NZ)
Title: Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
Inventor: GLOMBIK HEINER
IPC: A61P9/10
Filed: 2001-12-11
Abstract: 1,2-diphenzylazetidinones of the formula (I), method for producing these compounds, and medicaments containing said compounds are disclosed, wherein R1, R2, R3, R4, R5, and R6 are as defined in the specification. These diphenzylazetidinones are suitable for treating disorders of the lipid metabolism, for example, as hypolipidemics.
Patent NZ-533261-A (NZ)
Title: Method for controlling legionella in cooling towers
Inventor: COFFEY JOHN INNES
IPC: F28F25/00
Filed: 2002-11-25
Abstract: A method of controlling Legionella bacteria in cooling water systems is described. The method involves the heating of recirculating cooling water to temperatures of 70 DEG C for sufficient time to kill the bacteria, at least once every 10 days. The method functions best in combination with chemical bactericides.
Patent NZ-535318-A (NZ)
Title: Processes for the preparation of combretastatins
Inventor: MUTTI STEPHANE
IPC: C07D263/04
Filed: 2003-04-09
Abstract: Disclosed are processes for the preparation of combretastatins of general formula (I) in which A represents an amino group, comprising condensing a (3,4,5-trimethoxybenzyl)triphenylphosphonium salt with a 3-amino-4-methoxy benzaldehyde or condensing a (3-amino-4-methoxybenzyl)triphenylphosphonium salt with 3,4,5-trimethoxybenzaldehyde and reducing the nitro group in the presence of iron. Also disclosed is a process and intermediates for producing serine salts of formula (I) by way of reaction with a cyclic protected serine derivative of formula (IIb) to form an intermediate of formula (III) which is subsequently deprotected.
Patent NZ-536279-A (NZ)
Title: Use of a composition comprising formoterol and budesonide for symptomatic relief, when needed, in the prevention or treatment of an acute condition of asthma
Inventor: EKSTROM TOMMY
IPC: A61K31/165
Filed: 1999-06-10
Abstract: Disclosed herein is a use of a composition comprising, in admixture: (a) a first active ingredient which is formoterol, a pharmaceutically acceptable salt or solvate thereof or a solvate of such a salt; and (b) a second active ingredient which is budesonide; for the manufacture of a medicament for use for symptomatic relief, when needed, in the prevention or treatment of an acute condition of asthma and/or intermittent asthma and/or episodes in chronic
Patent NZ-536303-A (NZ)
Title: Production of cloned offspring from cooled carcasses
Inventor: STICE STEVEN L
IPC: A01K67/02
Filed: 2003-04-24
Abstract: Disclosed is a method of producing a cloned or genetically modified mammalian non-human embryo comprising: a) providing two or more cooled post-mortem tissue samples from two or more different animals; b) screening the samples for pre-selected physical, genetic and/or phenotypic criteria; c) transferring DNA from one or more donor cells derived from one or more of the animals to an oocyte to form a nuclear transfer unit; and d) culturing said nuclear transfer unit to establish said embryo. Also disclosed are embryos produced by the above method and the use of the above method to improve the characteristics of a herd.
Patent NZ-536463-A (NZ)
Title: Aqueous coating composition having improved acid etch and mar resistance
Inventor: CHUNG DING YU
IPC: C08G18/80
Filed: 2003-06-10
Abstract: Disclosed herein is an aqueous coating composition having a pH of 6.0-10.0 comprises 30 % to 70 % by weight of film-forming binder and correspondingly 70 % to 30 % by weight of an aqueous liquid carrier for the binder; wherein the binder comprises: a. 20 % to 95 % by weight, based on the weight of the binder, of a urethane oligomer having a weight average molecular weight of 300 to 2500 and having acid functionality and neutralized with an amine and to form a water-dispersible product; and b. 5 % to 80 % by weight, based on the weight of the binder, of a water-compatible alkylated melamine formaldehyde crosslinking agent. This aqueous coating composition provides a protective clear top coat finish that not only has good gloss and distinctness of image that provides an excellent appearance but that also has a high level of acid etch resistance and excellent mar resistance.
Patent NZ-537679-A (NZ)
Title: Profiled rail system for bridging floorcovering transitions
Inventor: SONDERMANN FRANK
Filed: 2005-01-14
Abstract: A profiled rail system (1) is used for bridging floor covering transitions, ends or staircase edges. The profiled rail system (1) has a base profile (2) and a covering profile (3). The base profile (2) has at least one vertical leg (6), on which an inner shell (9) of a rotary joint (10) is provided. This rotary joint (10) supports the covering profile (3) such that it can be pivoted. For this purpose, two webs (21) oriented downward are provided on the covering profile (3) and, in order to form an outer shell of the rotary joint (10), have at least two partly cylindrical inner contours (12) which lie one above another. These inner contours (12) are formed so as to match the inner shell (9) of the rotary joint (10). In this way, step by step adjustability of the covering profile (3) is implemented. The rotary joint (10) can be clicked as desired into respectively one of the partly cylindrical inner contours (12). In addition, the partly cylindrical inner contours (12) ensure pivotable mounting of the covering profile (3) with respect to the base profile (2).
Patent NZ-537916-A (NZ)
Title: Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant diseases
Inventor: EMIG PETER
IPC: A61P35/04
Filed: 2003-06-20
Abstract: Disclosed is an aryl- or heteroaryl-substituted piperazinylcarbonyl compound of formula 1, wherein: R1 is optionally substituted fluoren-9-one, isoxazole, cinnoline, isothiazole, isoquinoline, 9H-fluorene, 9H-xanthene and 1H-pyrazole, R2 is O or S, R3 is independently H, optionally substituted alkyl, halogen, COOH, CONH2, R4 is optionally substituted aryl, heteroaryl, alkylaryl, alkylhetaryl, and m and n are independently 0-3. The compounds are used in the manufacture of medicaments for the treatment of tumors in mammals.
Patent NZ-539444-A (NZ)
Title: Novel tunable hybrid adhesive system for wood bonding applications
Inventor: DOOLIN MICHAEL B
IPC: C08L31/04
Filed: 2004-03-08
Abstract: A product comprising two or more pieces of wood and/or wood containing substrate which are adhered together by using an adhesive system for wood is disclosed, wherein the adhesive system consists of a synergistic mixture of a melamine-formaldehyde resin, a phenol-formaldehyde resin, and an emulsion of a cross-linked polyvinyl acetate resin, wherein the adhesive mixture is cured with an acid.
Patent NZ-541543-A (NZ)
Title: Thin aqueous cataplasm having a support and a pressure-sensitive adhesive layer
Inventor: SHIRAI SADANOBU
IPC: A61K9/70
Filed: 2004-01-26
Abstract: A thin aqueous cataplasm material having a support and a pressure-sensitive adhesive layer (a plaster) having a specific component laminated thereon is disclosed, wherein the support comprises a fiber film comprising a composite fiber composed of a natural fiber and a soft plastic fiber entangled with each other and, heat-fused thereto, a soft plastic resin. The thin aqueous cataplasm is prepared by laminating an adhesive layer on a support, and said support consisting of a fiber film prepared by heat-fusing a soft plastic resin on a composite fiber prepared by entangling a natural fiber and a soft plastic fiber. The thin aqueous cataplasm material can retain a moisture-protecting effect of a skin and provide a user with comfortable feeling.
Patent NZ-541969-A (NZ)
Title: Purifying pneumolysin from Streptococcus pneumoniae in a single chromatographic step by binding it to a hydrophobic interaction column in the presence of detergent and high salt
Inventor: BIEMANS RALPH
IPC: C12P21/00
Filed: 2004-03-11
Abstract: Disclosed is a process for purifying bacterial cytolysins such as pneumococcal pneumolysin. A single chromatography step produces excellent purification of the cytolysin by binding soluble aggregated cytolysin to a hydrophobic interaction chromatography material in the presence of detergent and high salt.
Patent NZ-542842-A (NZ)
Title: Suspended insulated concrete floor with integral cast in beams
Inventor: LONSDALE CRAIG WALLACE
Filed: 2005-10-05
Abstract: A suspended concrete floor (2) is disclosed. It comprises of a layer of concrete (3) formed integrally with a plurality of spaced parallel beams (4), the beams (4) being formed and separated by panels of insulating material (5) which are attached to bottom layer (6) forming a lower surface of the floor. The concrete floor (2) is poured in situ while the insulating panels (5) and the bottom layer (6) are supported by scaffold (10) and plates (11) until cured.
Patent NZ-543622-A (NZ)
Title: Method of joining surfaces for producing wood based glued products
Inventor: NORLING HAKAN LARS ERIK
IPC: C09J5/04
Filed: 2004-05-05
Abstract: Disclosed is a method of joining surfaces, comprising in the following order: applying an adhesive composition (A), comprising a solvent, onto a first surface, drying off the solvent, partially or completely, by forced drying, to give the adhesive composition (A) a solids content of X weight %, directly after the drying step, applying a component (C), comprising a solvent, having a solids content of Z weight %, onto a second surface, wherein Z<X, bringing together the two surfaces so that the adhesive composition (A) is in contact with the component (C), and, pressing the two surfaces against each other. A method of producing a wood based glued product is also disclosed.
Patent NZ-544288-A (NZ)
Title: A transparent plastic pocket with resealable opening
Inventor: SLEE ESTER
Filed: 2003-07-18
Abstract: A page protector that consists of two transparent sheets 1, 2 joined along edges to form a pocket. One edge of the pocket has a longitudinal strengthening band 6 including apertures 7 for engagement with holding devices of a scrapbook album. The opening 9 into which photographs or album pages are inserted is releasably sealed and is formed at an edge opposite the strengthening band.
Patent NZ-545610-A (NZ)
Title: Improvements in or relating to tube couplings
Inventor: GUEST JOHN DEREK
IPC: F16L37/092
Filed: 2006-02-28
Abstract: A tube coupling comprises a coupling body having an open ended throughway to receive a tube, an annular shoulder in the throughway facing the open end of the throughway, an O-ring seal for sealing with a tube located against the annular shoulder in the throughway and a collet located in the open end of the throughway for locking a tube in the throughway. The collet has a head projecting out of the open end of the throughway and resilient arms extending into the throughway. The throughway has a cam surface adjacent the open end which is tapered towards the open end of the throughway with which the ends of the arms are engagable to force the arms inwardly with movement of the collet outwardly of the throughway into gripping engagement with a tube extending through the collet into the throughway. A ring is disposed in the throughway between the collet and O-ring seal. One side of the ring adjacent the collet has a ramp around its inner periphery to engage the ends of the collet arms when the collet is depressed into the throughway to release the arms from the tube and thereby allow release of a tube from the coupling body. The other side of the ring has a ramp around its inner periphery to engage the O-ring seal to hold the seal in alignment in the throughway when the collet is depressed into the throughway.